Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
2023 · Cancer Cell · 73 citations
https://doi.org/10.1016/j.ccell.2023.04.017
A
Anni Virtanen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
190
Papers
1.6K
Citations
19
h-index
29
i10-index
Anni Virtanen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & Cervical Cancer and HPV Research. The author has an h-index of 19, co-authored 162 publications.
ORCID: 0000-0002-7467-8434Papers by this author
worksCancer Incidence and Mortality in the Oldest Old: A Nationwide Study in Finland
2020 · American Journal of Epidemiology · 33 citations
https://doi.org/10.1093/aje/kwaa236
The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland
2015 · BMC Women s Health · 15 citations
https://doi.org/10.1186/s12905-015-0261-7
Health inequalities among Russian-born immigrant women in Finland: Longitudinal analysis on cervical cancer incidence and participation in screening
2022 · Journal of Migration and Health · 11 citations
https://doi.org/10.1016/j.jmh.2022.100117
H&E image analysis pipeline for quantifying morphological features
2023 · Journal of Pathology Informatics · 11 citations
https://doi.org/10.1016/j.jpi.2023.100339
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer
2025 · Cell Reports Medicine · 6 citations
https://doi.org/10.1016/j.xcrm.2025.102316
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat